SMS Pharmaceuticals Hits 52-Week High of Rs 494: What's Driving the Stock Today

Published: 22 September 2026 at 10:18 AM IST

SMS Pharmaceuticals Share Price moved higher on 22 September 2026, with the stock closing at Rs 491.65, up 5.4% from the previous close of Rs 466.45. During the session, the counter touched Rs 494.40, which is also its fresh 52-week high, while market capitalisation stood at Rs 4,148.32 crore. The day opened at Rs 466.5 and traded between Rs 466.5 and Rs 494.4.

For readers tracking SMS Pharmaceuticals Share Price Today, the key fact is straightforward: the session produced a new one-year high, but the supplied data does not establish a company-specific catalyst. Univest flags the event because the price action is new for the past 52 weeks, and the move keeps SMS Pharmaceuticals Stock News in focus for market participants monitoring Indian Stock Market updates.

SMS Pharmaceuticals Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 491.65
Previous Close	Rs 466.45
Today's Move	+Rs 25.2 (+5.4%)
Open	Rs 466.5
High	Rs 494.4
Low	Rs 466.5
Turnover	Rs 1.94 crore
Market Capitalisation	Rs 4,148.32 crore

SMS Pharmaceuticals Ltd. (SMSPHARMA) traded at Rs 491.65 versus the previous close of Rs 466.45, a rise of 5.4%. The stock opened at Rs 466.5, reached a high of Rs 494.4 and touched a low of Rs 466.5.

SMS Pharmaceuticals Share Price Today shows a clear session of upward movement from Rs 466.45 to Rs 491.65, a gain of Rs 25.2 or 5.4%. The stock opened almost exactly at the previous close at Rs 466.5, then advanced to Rs 494.4, before ending the day at Rs 491.65. That means the close finished only Rs 2.75 below the session high and Rs 25.2 above the prior close.

What exactly happened today is a fresh 52-week high at Rs 494.40, which also makes this a yearly high and a 52-week peak. The session turnover was Rs 1.94 crore, which is the factual traded value for the day. For SMS Pharmaceuticals Share Price, the important takeaway is the combination of a strong daily move and a new high within the last year, while the data itself does not establish why the stock advanced. Univest tracks such moves because they often become part of broader Stocks in News and Market News searches.

That price action is best read as a factual event update rather than a commentary on cause. The next section on SMS Pharmaceuticals Fundamental Analysis places the move in valuation and earnings context.

SMS Pharmaceuticals Ltd. (SMSPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 4,148.32 crore
P/E Ratio	42.66x
P/B Ratio	5.42x
ROE	12.49%
ROCE	13.32%
EPS	Rs 10.93
Book Value Per Share	Rs 86.06
Dividend Yield	0.09%

SMS Pharmaceuticals Ltd. (SMSPHARMA) fundamental metrics show P/E 42.66x, P/B 5.42x, ROE 12.49%, ROCE 13.32%. These figures provide context only and are not a buy or sell signal.

SMS Pharmaceuticals Ltd. has a market capitalisation of Rs 4148.32 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 42.66x, P/B at 5.42x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 12.49% and ROCE of 13.32%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.93, book value per share of Rs 86.06, dividend yield of 0.09%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.39x, median ROE of 11.7%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	42.66x
Benchmark Median P/E	32.39x
Benchmark Average P/E	49.55x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	5.42x
Benchmark Median P/B	2.98x
Company ROE	12.49%
Benchmark Median ROE	11.7%
Company ROCE	13.32%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 4,148.32 crore
Benchmark Median Market Cap	Rs 729.99 crore

SMS Pharmaceuticals Ltd. (SMSPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 42.66x, which is above the benchmark median of 32.39x, a difference of +31.71%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROE of 12.49%, which is above the benchmark median of 11.7%, a difference of +6.75%. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a ROCE of 13.32%, which is below the benchmark median of 13.65%, a difference of -2.42%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Aarti Drugs Ltd.	AARTIDRUGS	3,940.58	20.79	2.49	13.36	12.04
Gufic Biosciences Ltd.	GUFICBIO	4,368.31	59.48	6.36	10.14	12.56
Unichem Laboratories Ltd.	UNICHEMLAB	3,840.63	12.47	1.38	9.81	10.68
RPG Life Sciences Ltd.	RPGLIFE	4,640.19	39.74	7.19	20.28	26.99
Kwality Pharmaceuticals Ltd.	KPL	3,606.14	49.12	11.17	22.67	24.01

SMS Pharmaceuticals Ltd. (SMSPHARMA) has a P/E ratio of 42.66x compared with the displayed peer median of 39.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 12.49% compares with a peer median of 13.36% across the companies shown in the table. ROCE stood at 13.32% versus the displayed peer median of 12.56%, providing a capital-efficiency comparison. SMS Pharmaceuticals Ltd. (SMSPHARMA) has a market capitalisation of Rs 4,148.32 crore. Among the 5 peers shown, 2 have a larger market capitalisation.

Why Investors Are Watching SMS Pharmaceuticals

• SMS Pharmaceuticals Share Price touched a fresh 52-week high of Rs 494.40 during the session.
• The stock closed at Rs 491.65, up Rs 25.2 or 5.4% from the previous close of Rs 466.45.
• Market capitalisation stood at Rs 4,148.32 crore for SMS Pharmaceuticals Share Price Today.
• P/E of 42.66 and P/B of 5.42 place the stock above the industry median on both valuation measures.
• ROE of 12.49% and ROCE of 13.32% provide current profitability context for SMS Pharmaceuticals Stock Analysis.

About SMS Pharmaceuticals

SMS Pharmaceuticals Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied financial record shows revenue of Rs 2,069.65 crore for Jun 2026 and net profit of Rs 209.09 crore for the same period. Earlier reported revenue and profit data across recent quarters show movement through the year, including revenue of Rs 2,379.48 crore in Mar 2026 and net profit of Rs 327.14 crore in Mar 2026. These figures help frame SMS Pharmaceuticals Share Price within the company’s reported financial history and sector classification.

For readers following SMS Pharmaceuticals Company News and SMS Pharmaceuticals Latest News, the current market event is a fresh 52-week high rather than a broader business commentary. Univest keeps the discussion tied to verified share price, market cap and company financials.

Track SMS Pharmaceuticals Share Price on Univest

Use SMS Pharmaceuticals Ltd. (SMSPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track SMS Pharmaceuticals Share Price on Univest for live share price updates, market cap, shareholding pattern, 52-week levels, financial ratios and company news in one place. Univest also presents the latest stock analysis, sector context and peer comparison so readers can review SMS Pharmaceuticals Share Price Today alongside broader market data.

Frequently Asked Questions

Why did SMS Pharmaceuticals Share Price hit a fresh 52-week high today?

Ans. The supplied data confirms that SMS Pharmaceuticals Share Price touched Rs 494.40, its fresh 52-week high, while closing at Rs 491.65. The dataset does not establish a company-specific catalyst for the move.

What was the closing price of SMS Pharmaceuticals Share Price today?

Ans. SMS Pharmaceuticals Share Price closed at Rs 491.65, up Rs 25.2 or 5.4% from the previous close of Rs 466.45. The session also recorded a new yearly high at Rs 494.40.

What was the 52-week high for SMS Pharmaceuticals Share Price?

Ans. The fresh 52-week high for SMS Pharmaceuticals Share Price was Rs 494.40. That also represents the day’s high and marks the stock’s one-year peak in the supplied market data. The stock moved 5.4% during the session.

What is the market capitalisation of SMS Pharmaceuticals?

Ans. SMS Pharmaceuticals has a market capitalisation of Rs 4,148.32 crore. Within the same-industry benchmark, that places it above the median company size of Rs 729.99 crore. The company operates in the Healthcare sector.

How does SMS Pharmaceuticals Share Price compare with the industry P/E?

Ans. SMS Pharmaceuticals Share Price trades at a P/E of 42.66, above the same-industry median of 32.39 and below the industry average of 49.55. That is valuation context, not a rating.

How do ROE and ROCE look for SMS Pharmaceuticals?

Ans. ROE stands at 12.49% and ROCE at 13.32%. ROE is slightly above the industry median, while ROCE is slightly below the industry median and just under the industry average. ROE stands at 12.49%.

Which sector and industry does SMS Pharmaceuticals belong to?

Ans. SMS Pharmaceuticals belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The peer set supplied for analysis also comes from the same industry benchmark of 199 companies. The stock belongs to the Healthcare sector.

How does SMS Pharmaceuticals compare with peers on market cap?

Ans. SMS Pharmaceuticals has a market cap of Rs 4,148.32 crore, above several peers such as Unichem Laboratories and Ind-Swift Laboratories, but below larger names like FDC and Orchid Pharma in the supplied peer set.

What should readers monitor next for SMS Pharmaceuticals Share Price?

Ans. Readers can monitor whether SMS Pharmaceuticals Share Price continues to hold around its fresh 52-week high, along with updates in valuation, profitability and sector comparisons. Univest tracks these metrics in the stock page and company news flow.